Global /India /Healthcare /Medical Devices /533212
chevron_leftBack
GKB Ophthalmics Ltd. logo

GKB Ophthalmics Ltd.

533212
BSE: 533212 Delayed
68.98INR 2.7%
0.7232 USD
As of 6 June 2026, GKB Ophthalmics Ltd. has a market cap of $3.63M USD, ranking #45563 globally and #4106 in India. It ranks #4035 in the Healthcare sector, and #854 in the Medical Devices industry.
Global Rank
45563
Country Rank
4106
Sector Rank
4035
Industry Rank
854
Key Stats
Market Cap
$3.63MUSD
347.7M INR
Enterprise Value
$4.27MUSD
407.36M INR
Revenue (TTM)
$15.7MUSD
1.5B INR
EBITDA (TTM)
$229.53KUSD
21.89M INR
Net Income (TTM)
-$263.27KUSD
-25.21M INR
EBITDA Margin
1.5%
Profit Margin
-1.7%
PS Ratio
0.2
PB Ratio
0.6
EV/EBITDA
18.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Krishna Gupta open_in_new
Employees
170
Founded
1981
Website
gkb.net open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.7% -4.3% 24% 21% 2.5% -13%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
533212 (GKB)
GKB Ophthalmics Ltd
ISIN: INE265D01015
Shares Out.:
5.041M1
TV:
SA:
YF:
GF:
BA:
MS:
68.98 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About GKB Ophthalmics Ltd.

GKB Ophthalmics Limited engages in the manufacture and sale of unfinished ophthalmic lenses in India and internationally. The company offers semi-finished organic lenses, including single vision, bifocal, and progressive. GKB Ophthalmics Limited was incorporated in 1981 and is based in Mapusa, India.

Similar Companies

Industry: Medical Devices (India)
Name
Market Cap diff.
PE
LENSKART
$9.43B
902.85B INR
260K%
171.7
POLYMED
$1.61B
154.07B INR
44K%
44.3
$126.06M
12.07B INR
3K%
85.8
$108.66M
10.4B INR
3K%
113.4
OSELDEVICE
$98.94M
9.47B INR
3K%
30.5
543363
$54.74M
5.24B INR
1K%
26.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
5M%
25.8
$160.73B
4M%
56.7
$159.07B
4M%
25.6
DHR
$126.55B
3M%
34.7
SYK
$120.69B
3M%
38.3
MDT
$101.9B
3M%
22.2
chevron_leftBack